HCA

SEC source: 0001209191-18-007219 · doc4.xml · nonDerivative · entry 5

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,270.0531

F1 · balance_after: Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-18-007219 · doc4.xml · nonDerivative · entry 4

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,207.0531

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-18-007219 · doc4.xml · nonDerivative · entry 3

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,082.0531

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-18-007219 · doc4.xml · nonDerivative · entry 2

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,332.0531

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-18-007219 · doc4.xml · nonDerivative · entry 1

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,182.0531

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-18-007221 · doc4.xml · derivative · entry 1

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,020

Underlying: Common Stock · 32,020 shares

Expires 2028-01-31

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019.

SEC source: 0001209191-18-007215 · doc4.xml · derivative · entry 1

CAMPBELL VICTOR L · CIK 0001216831 · SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,300

Underlying: Common Stock · 18,300 shares

Expires 2028-01-31

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019.

SEC source: 0001209191-18-006619 · doc4.xml · derivative · entry 8

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,654

Underlying: Common Stock · 1,846 shares

Expires 2022-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of options, exercise of stock appreciation rights and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F5 · derivative.exercise_date: The stock appreciation right vested in four equal annual installments beginning on February 8, 2013.

SEC source: 0001209191-18-006619 · doc4.xml · derivative · entry 7

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 62,500 shares

Expires 2022-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of options, exercise of stock appreciation rights and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets.

SEC source: 0001209191-18-006619 · doc4.xml · derivative · entry 6

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,025 shares

Expires 2020-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F1 · kind: The exercise of options, exercise of stock appreciation rights and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

SEC source: 0001209191-18-006619 · doc4.xml · nonDerivative · entry 4

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,981

F1 · kind: The exercise of options, exercise of stock appreciation rights and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-18-006619 · doc4.xml · nonDerivative · entry 3

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,732

F1 · kind: The exercise of options, exercise of stock appreciation rights and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-18-006619 · doc4.xml · nonDerivative · entry 2

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,757

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of options, exercise of stock appreciation rights and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-18-006619 · doc4.xml · nonDerivative · entry 1

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,411

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of options, exercise of stock appreciation rights and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-18-007251 · doc4a.xml · nonDerivative · entry 1

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,581

F1 · kind: The exercise of options, exercise of stock appreciation rights and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · shares: Due to an administrative error, the original Form 4 dated 2/1/2018 was filed reporting that 32,751 shares were withheld in connection with an exercise of stock appreciation rights. The correct number of shares withheld was 34,151.

SEC source: 0001209191-18-006100 · doc4.xml · derivative · entry 6

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,025

Underlying: Common Stock · 23,025 shares

Expires 2020-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

SEC source: 0001209191-18-006100 · doc4.xml · derivative · entry 5

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 35,150 shares

Expires 2020-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · derivative.exercise_date: One-third of the option vested on February 10, 2013 and the remainder vested upon a change in control (as defined in the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates as Amended and Restated) of the Issuer which occurred effective November 1, 2013.

F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

SEC source: 0001209191-18-006100 · doc4.xml · nonDerivative · entry 3

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,386

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-18-006100 · doc4.xml · nonDerivative · entry 2

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,561

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-18-006100 · doc4.xml · nonDerivative · entry 1

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,536

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-17-066675 · doc4.xml · derivative · entry 7

CAMPBELL VICTOR L · CIK 0001216831 · SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,158

Underlying: Common Stock · 5,600 shares

Expires 2019-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F2 · derivative.exercise_date: The option was scheduled to vest in three equal annual installments beginning on August 27, 2012. A change in control of the Issuer occurred effective November 1, 2013, resulting in the accelerated vesting of the option as to the shares that remained unvested.

F3 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

SEC source: 0001209191-17-066675 · doc4.xml · nonDerivative · entry 1

CAMPBELL VICTOR L · CIK 0001216831 · SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,875

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-066518 · doc4.xml · derivative · entry 3

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,400 shares

Expires 2021-11-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · derivative.exercise_date: The option vested in two equal annual installments beginning on November 2, 2014.

SEC source: 0001209191-17-066518 · doc4.xml · nonDerivative · entry 2

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,373.4951

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · balance_after: Includes 1,391.4951 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-17-066518 · doc4.xml · nonDerivative · entry 1

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,773.4951

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · balance_after: Includes 1,391.4951 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-17-062630 · doc4.xml · derivative · entry 3

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,400

Underlying: Common Stock · 2,150 shares

Expires 2021-11-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · derivative.exercise_date: The option vested in two equal annual installments beginning on November 2, 2014.

SEC source: 0001209191-17-062630 · doc4.xml · nonDerivative · entry 2

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,326.0062

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-17-062630 · doc4.xml · nonDerivative · entry 1

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,476.0062

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-18-010020 · doc5.xml · nonDerivative · entry 8

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly by GRATs

Disclosed balance after: 3,501,606.4752

F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

F2 · ownership.nature: The Reporting Person is trustee of three grantor retained annuity trusts for the benefit of her children, and the Reporting Person's spouse is the trustee of nine grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person may, accordingly, be deemed to be the beneficial owner of the aggregate of 35,190 shares of common stock of HCA Healthcare, Inc. held by such trusts. In addition, the Reporting Person may be deemed to be the beneficial owner of the 3,466,416.4752 units of Hercules held by such trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

F7 · ownership.nature: On November 20, 2017, The Patricia Frist Elcan 2015 Annuity Trust III transferred an aggregate of 13,073 units of Hercules to three grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person is trustee of The Patricia Frist Elcan 2015 Annuity Trust III and the Reporting Person's spouse is trustee of the three grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person may therefore be deemed the beneficial owner of the units of Hercules held by these grantor retained annuity trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

SEC source: 0001209191-18-010020 · doc5.xml · nonDerivative · entry 7

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II by Patricia Frist Elcan 2015 Annuity Trust III

Disclosed balance after: 0

F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

F7 · ownership.nature: On November 20, 2017, The Patricia Frist Elcan 2015 Annuity Trust III transferred an aggregate of 13,073 units of Hercules to three grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person is trustee of The Patricia Frist Elcan 2015 Annuity Trust III and the Reporting Person's spouse is trustee of the three grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person may therefore be deemed the beneficial owner of the units of Hercules held by these grantor retained annuity trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

SEC source: 0001209191-18-007223 · doc4.xml · nonDerivative · entry 1

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,482

SEC source: 0001209191-17-061862 · doc4.xml · nonDerivative · entry 1

CAMPBELL VICTOR L · CIK 0001216831 · SVP

10b5-1 filing: Not disclosed

Ownership: Indirect · By AWC 2012 Trust (Spouse, Trustee)

Disclosed balance after: 26,478

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.76 to $75.89, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-17-060414 · doc4.xml · nonDerivative · entry 1

CAMPBELL VICTOR L · CIK 0001216831 · SVP

10b5-1 filing: Not disclosed

Ownership: Indirect · By AWC 2012 Trust (Spouse, Trustee)

Disclosed balance after: 34,478

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.00 to $78.0175, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-17-059280 · doc4.xml · derivative · entry 1

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,010

Underlying: Common Stock · 11,010 shares

Expires 2027-11-01

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on November 1, 2018.

SEC source: 0001209191-17-057526 · doc4.xml · derivative · entry 3

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,550

Underlying: Common Stock · 2,150 shares

Expires 2021-11-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · derivative.exercise_date: The option vested in two equal annual installments beginning on November 2, 2014.

SEC source: 0001209191-17-057526 · doc4.xml · nonDerivative · entry 2

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,326.0062

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-17-057526 · doc4.xml · nonDerivative · entry 1

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,476.0062

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-17-053357 · doc4.xml · derivative · entry 3

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,700

Underlying: Common Stock · 2,150 shares

Expires 2021-11-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · derivative.exercise_date: The option vested in two equal annual installments beginning on November 2, 2014.

SEC source: 0001209191-17-053357 · doc4.xml · nonDerivative · entry 2

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,326.0062

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · balance_after: Includes 1,344.0062 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-17-053357 · doc4.xml · nonDerivative · entry 1

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,476.0062

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · balance_after: Includes 1,344.0062 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-18-010020 · doc5.xml · nonDerivative · entry 6

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly by GRATs

Disclosed balance after: 3,488,533.4752

F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

F2 · ownership.nature: The Reporting Person is trustee of three grantor retained annuity trusts for the benefit of her children, and the Reporting Person's spouse is the trustee of nine grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person may, accordingly, be deemed to be the beneficial owner of the aggregate of 35,190 shares of common stock of HCA Healthcare, Inc. held by such trusts. In addition, the Reporting Person may be deemed to be the beneficial owner of the 3,466,416.4752 units of Hercules held by such trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

F6 · ownership.nature: On August 24, 2017, The Patricia Frist Elcan 2014 Annuity Trust V transferred an aggregate of 39,303 units of Hercules to three grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person is trustee of The Patricia Frist Elcan 2014 Annuity Trust V and the Reporting Person's spouse is trustee of the three grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person may therefore be deemed the beneficial owner of the units of Hercules held by these grantor retained annuity trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

SEC source: 0001209191-18-010020 · doc5.xml · nonDerivative · entry 5

Elcan Patricia F · CIK 0001433376 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II by Patricia Frist Elcan 2014 Annuity Trust V

Disclosed balance after: 0

F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein.

F6 · ownership.nature: On August 24, 2017, The Patricia Frist Elcan 2014 Annuity Trust V transferred an aggregate of 39,303 units of Hercules to three grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person is trustee of The Patricia Frist Elcan 2014 Annuity Trust V and the Reporting Person's spouse is trustee of the three grantor retained annuity trusts for the benefit of the Reporting Person's children. The Reporting Person may therefore be deemed the beneficial owner of the units of Hercules held by these grantor retained annuity trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

SEC source: 0001209191-17-049475 · doc4.xml · derivative · entry 3

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,850

Underlying: Common Stock · 2,150 shares

Expires 2021-11-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · derivative.exercise_date: The option vested in two equal annual installments beginning on November 2, 2014.

SEC source: 0001209191-17-049475 · doc4.xml · nonDerivative · entry 2

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,212.555

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-17-049475 · doc4.xml · nonDerivative · entry 1

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,362.555

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-17-049034 · doc4.xml · derivative · entry 6

Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,418 shares

Expires 2017-11-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F4 · derivative.exercise_date: The option vested in two equal annual installments beginning on November 15, 2008.

F3 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

SEC source: 0001209191-17-049034 · doc4.xml · derivative · entry 5

Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 57,627 shares

Expires 2017-11-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F2 · derivative.exercise_date: The option vested in equal increments at the end of fiscal years 2007, 2008 and 2009 based upon the achievement of certain annual EBITDA performance targets.

F3 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

SEC source: 0001209191-17-049034 · doc4.xml · nonDerivative · entry 2

Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,118.6115

SEC source: 0001209191-17-049034 · doc4.xml · nonDerivative · entry 1

Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,956.6115

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-18-007231 · doc4.xml · nonDerivative · entry 1

JOHNSON R MILTON · CIK 0001216841 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 426,935